NasdaqCM:OCGNBiotechs
Ocugen (OCGN) Valuation Check As Loss-Making Q1 2026 And US$103.5m Convertible Notes Reset Expectations
Earnings and convertible notes set the stage for Ocugen stock
Ocugen (OCGN) is back in focus after reporting first quarter 2026 results and closing a US$103.5 million convertible note offering, a combination that puts both its cash needs and capital structure in the spotlight.
See our latest analysis for Ocugen.
The recent 1 day share price return of 2.35% decline and 7 day share price return of 13.39% decline suggest some short term profit taking after the earnings release and convertible...